Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stryker finalizes acquisition of French joint replacement firm

EditorEmilio Ghigini
Published 03/21/2024, 07:44 AM
Updated 03/21/2024, 07:44 AM
© Reuters.

MAHWAH, N.J. - Stryker Corporation (NYSE: NYSE:SYK), a prominent player in the medical technology industry, announced the completion of its acquisition of SERF SAS, a distinguished French joint replacement company, enhancing its global orthopaedics portfolio. The transaction, which was initially revealed to the public without a disclosed sum, was finalized today.

The integration of SERF SAS into Stryker's operations is poised to bolster the company's product offerings in the joint replacement sector. SERF SAS, with its pioneering Dual Mobility Cup and a history spanning over five decades, is set to complement Stryker's existing market presence in Europe, particularly in France, and contribute to the expansion of its global footprint in orthopaedic solutions.

Katherine Truppi, President of Stryker's Joint Replacement division, expressed enthusiasm about the merger, stating that the acquisition "reinforces our dedication to orthopaedic excellence." Truppi also welcomed the SERF SAS team and emphasized the combined efforts to propel product innovation and customer satisfaction.

Similarly, Mathieu Badard, Vice President and General Manager of Stryker's Joint Replacement division in Europe, remarked on the trusted legacy of SERF SAS's product portfolio within the orthopaedic industry and the excitement surrounding the unification of their product lines. The strategic move is expected to extend Stryker's reach within Europe and facilitate increased patient access to differentiated joint replacement products.

Stryker is recognized as a global leader in medical technologies, striving to improve healthcare outcomes through a broad range of innovative products and services. The company's influence extends to over 150 million patients annually across various medical sectors, including MedSurg, Neurotechnology, Orthopaedics, and Spine.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

SERF SAS, based in Décines-Charpieu, France, has a longstanding international presence in the large joint replacement market and is renowned for its innovative contributions, such as the original Dual Mobility Cup.

The acquisition's completion is based on a press release statement and is part of Stryker's ongoing efforts to expand and enhance its product lines and global market reach.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.